The MSc, which takes 2 years to complete, will offer skills in health services research, health economics, outcomes research, and health policy.
It is aimed at professionals from a wide range of backgrounds, including the medical professions, pharmaceutical and medical devices industries, healthcare management, government and non-governmental organisations.
Professor Elias Mossialos, Head of Department of Health Policy at LSE said: “Skills in evaluating health care interventions and outcomes are increasingly important for professionals in many sectors. However, until now there has been a lack of postgraduate opportunities tailored to health care professionals in employment. The new Executive MSc will address this gap.
“The combination of LSE's world-leading teaching and research excellence and NICE’s standing as a national authority and global leader in health technology assessment and guidance development will enable us to offer an unparalleled degree of rigour and professional relevance.”
Sir Andrew Dillon, chief executive of NICE, said: “This is a great opportunity for professionals who are looking to enhance their skills in the healthcare industry. NICE has had nearly 20 years’ experience in evidence-based healthcare decision making and we are excited to be supporting LSE to share our expertise.”
The MSc in Evaluation of Health Care Interventions and Outcomes will open for applications from September 2018 and the course will begin in April 2020.